Imperial Innovations Group Share News (IVO)

Imperial Innovations Says Storm Therapeutics Raises New Funds

DIRECTOR DEALINGS: Incoming Imperial Innovations Chairman Buys Shares

Director dealings: new Imperial Innovations chairman dips in

(ShareCast News) - Imperial Innovations' chairman designate took the opportunity to buy shares in the company after they were hit by disappointing news about one of the company's investments. David Newlands, who is set to become non-executive chairman on 1 August, bought his first 100,000 shares at

BROKER RATINGS SUMMARY: RBC Downgrades Circassia To Sector Perform

Imperial Innovations disappointed after Circassia drug test

(ShareCast News) - Imperial Innovations noted top-line results from a Circassia Pharmaceuticals drug study on Monday, after Circassia's share price plummeted in the wake of the cat allergy treatment's failure to perform against a placebo. At 1230 BST, shares in Imperial were down 3.87% at 418.3p. I

Circassia Pharmaceuticals: "Dramatic" Placebo Effect In Allergy Study

Imperial Innovations celebrates Cell Medica collaboration

(ShareCast News) - Imperial Innovations celebrated success at one of its investee companies on Friday, noting the announcement from Cell Medica of an exclusive licensing agreement and co-development partnership with the Baylor College of Medicine to create next-generation cellular immunotherapy prod

Imperial Innovations' Cell Medica Strikes Deal With Baylor College In US

Imperial Innovations: Woodford Gets FCA Approval For 21.3% Stake (ALLISS)

Imperial Innovations Invests Further GBP2.5 Million In Featurespace

Imperial Innovations Invests GBP1.8 Million In Inflowmatix Funding

Imperial Innovations appoints David Newlands as chairman

(ShareCast News) - Imperial Innovations announced a new chairman on Wednesday, appointing David Newlands to the post in a non-executive capacity with effect from the start of its new financial year - 1 August. The AIM-traded firm said that, after its announcement on 21 March that Dr Martin Knight wo

Imperial Innovations Names Newlands As Successor To Chairman Knight

Imperial Innovations Backs Nexeon In GBP30 Million Funding Round

Imperial Innovations investment in Stanmore Implants pays off

(ShareCast News) - Imperial Innovations Group was looking forward to a cash windfall on Friday, as SIW Holdings sold its Stanmore Implants Worldwide business to Stryker Corporation for £35.6m. Through Imperial's interest in SIW Holdings, it will share in the net proceeds of around £4.8m once they ha